Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices
Chemical Research in Toxicology · 16.09.2024 · 37 (9) · 1456-1483
DOI: 10.1021/acs.chemrestox.4c00234 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemical Research in Toxicology, online erschienen am 19.08.2024. Verfasst von Krishna Moorthy Manchuri und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Jawaharlal Nehru Technological University Anantapur, Ananthapuramu, Andhra Pradesh 515002, India. Hauptthemen laut MEDLINE: Drug Contamination, Nitrosamines. Die Arbeit wurde bisher 68-mal zitiert (Crossref) und nennt 295 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Since 2018, N-nitrosamine impurities have become a widespread concern in the global regulatory landscape of pharmaceutical products. This concern arises due to their potential for contamination, toxicity, carcinogenicity, and mutagenicity and their presence in many active pharmaceutical ingredients, drug products, and other matrices. N-Nitrosamine impurities in humans can lead to severe chemical toxicity effects. These include carcinogenic effects, metabolic disruptions, reproductive harm, liver diseases, obesity, DNA damage, cell death, chromosomal alterations, birth defects, and pregnancy loss. They are particularly known to cause cancer (tumors) in various organs and tissues such as the liver, lungs, nasal cavity, esophagus, pancreas, stomach, urinary bladder, colon, kidneys, and central nervous system. Additionally, N-nitrosamine impurities may contribute to the development of Alzheimer's and Parkinson's diseases and type-2 diabetes. Therefore, it is very important to control or avoid them by enhancing effective analytical methodologies using cutting-edge analytical techniques such as LC-MS, GC-MS, CE-MS, SFC, etc. Moreover, these analytical methods need to be sensitive and selective with suitable precision and accuracy, so that the actual amounts of N-nitrosamine impurities can be detected and quantified appropriately in drugs. Regulatory agencies such as the US FDA, EMA, ICH, WHO, etc. need to focus more on the hazards of N-nitrosamine impurities by providing guidance and regular updates to drug manufacturers and applicants. Similarly, drug manufacturers should be more vigilant to avoid nitrosating agents and secondary amines during the manufacturing processes. Numerous review articles have been published recently by various researchers, focusing on N-nitrosamine impurities found in previously notified products, including sartans, metformin, and ranitidine. These impurities have also been detected in a wide range of other products. Consequently, this review aims to concentrate on products recently reported to contain N-nitrosamine impurities. These products include rifampicin, champix, famotidine, nizatidine, atorvastatin, bumetanide, itraconazole, diovan, enalapril, propranolol, lisinopril, duloxetine, rivaroxaban, pioglitazones, glifizones, cilostazol, and sunitinib.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Jawaharlal Nehru Technological University Anantapur, Ananthapuramu, Andhra Pradesh 515002, India.
- Analytical Research and Development, IPDO, Dr. Reddy's Laboratories Limited, Hyderabad 500090, India.
- Department of Chemistry, Acharya Nagarjuna University, Nagarjuna Nagar, Guntur, Andhra Pradesh 522510, India.
ORCID-Profile: Krishna Moorthy Manchuri, Mahammad Ali Shaik, Naziya Sultana
Zitieren
APA
Manchuri, K. M., Shaik, M. A., Gopireddy, V. S. R., Naziya Sultana, & Gogineni, S. (2024). Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices. Chemical Research in Toxicology, 37(9), 1456-1483. https://doi.org/10.1021/acs.chemrestox.4c00234
Vancouver
Manchuri KM, Shaik MA, Gopireddy VSR, Naziya Sultana, Gogineni S. Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices. Chemical Research in Toxicology. 2024;37(9):1456-1483. doi:10.1021/acs.chemrestox.4c00234
BibTeX
@article{Manchuri2024,
author = {Manchuri, Krishna Moorthy and Shaik, Mahammad Ali and Gopireddy, Venkata Subba Reddy and Naziya Sultana and Gogineni, Sreenivasarao},
title = {Analytical Methodologies to Detect N-Nitrosamine Impurities in Active Pharmaceutical Ingredients, Drug Products and Other Matrices},
journal = {Chemical Research in Toxicology},
year = {2024},
volume = {37},
number = {9},
pages = {1456--1483},
doi = {10.1021/acs.chemrestox.4c00234}
}
EUVIMED